VolitionRx Limited VNRX
0.20 USD +0.01 (+4.09%)
Nov 4, 2026, 1:45 PM EST
0.1949 Day range 0.204
0.16 52-week range 9.60
- YTD
- -96.14%
- 1 year
- -97.77%
Analyst view
Consensus: buy
Buy
Price target (mean) 3.34 +1562.5% upside
Now 0.2009
- Target (low)
- 2.00
- Target (mean)
- 3.34
- Target (high)
- 5.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.05 | -0.06 – -0.03 | -0.11 | +54.5% | 545.34K | +123.5% | 3 |
| Next quarter | -0.06 | -0.06 – -0.06 | -0.10 | +40.0% | 800.00K | +366.4% | 1 |
| Current year | -0.305 | -0.33 – -0.28 | -0.4956 | +38.5% | 1.56M | +101.2% | 4 |
| Next year | -0.16667 | -0.22 – -0.08 | -0.305 | +45.3% | 9.39M | +501.8% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 22, 2024 | Benchmark | Reiterated | — | Hold |
| Nov 15, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 1, 2024 | EF Hutton | Maintained | Buy | Buy |
| Aug 16, 2024 | Benchmark | Reiterated | — | Hold |
| Jun 7, 2024 | EF Hutton | Maintained | Buy | Buy |
| May 16, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 14, 2024 | EF Hutton | Maintained | Buy | Buy |
| Mar 27, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 27, 2024 | EF Hutton | Maintained | Buy | Buy |
| Jan 2, 2024 | EF Hutton | Reiterated | Buy | Buy |
| Nov 21, 2023 | EF Hutton | Reiterated | Buy | Buy |
| Nov 16, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 30, 2023 | EF Hutton | Initiated | — | Buy |
| Aug 16, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Mar 16, 2023 | EF Hutton | Reiterated | — | Buy |
| Feb 1, 2023 | Benchmark | Downgrade | Buy | Hold |
| Dec 19, 2022 | EF Hutton | Initiated | — | Buy |
| Aug 23, 2022 | Maxim Group | Maintained | — | Buy |
| Aug 15, 2022 | Aegis Capital | Maintained | — | Buy |
| Nov 16, 2021 | Aegis Capital | Maintained | — | Buy |
| Mar 10, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jan 25, 2021 | Aegis Capital | Maintained | — | Buy |
| Aug 19, 2020 | Aegis Capital | Maintained | — | Buy |
| May 6, 2020 | Aegis Capital | Initiated | — | Buy |
| May 16, 2018 | Maxim Group | Initiated | — | Buy |
| Feb 1, 2016 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 25, 2015 | Benchmark | Initiated | — | Buy |
